These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 24359931

  • 1. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
    Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF.
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
    [Abstract] [Full Text] [Related]

  • 2. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
    Yi MY, Wang PY, Huang HJ, Liu YC.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):457-62. PubMed ID: 16677571
    [Abstract] [Full Text] [Related]

  • 3. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, Pirzadeh T, Pajand O.
    Infect Genet Evol; 2014 Jun 21; 24():187-92. PubMed ID: 24694825
    [Abstract] [Full Text] [Related]

  • 4. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY, Ko KS.
    Int J Antimicrob Agents; 2012 Aug 21; 40(2):168-72. PubMed ID: 22633564
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S, Ghozzi R, Burghoffer B, Arlet G, Redjeb S.
    Pathol Biol (Paris); 2009 Aug 21; 57(7-8):530-5. PubMed ID: 18977099
    [Abstract] [Full Text] [Related]

  • 6. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar 21; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 7. Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-group 1A allele.
    Shu JC, Su LH, Chiu CH, Kuo AJ, Liu TP, Lee MH, Su IN, Wu TL.
    Microb Drug Resist; 2015 Apr 21; 21(2):149-57. PubMed ID: 25386722
    [Abstract] [Full Text] [Related]

  • 8. Molecular typing and resistance mechanisms of carbapenem resistant Pseudomonas aeruginosa isolated from a Chinese surgical intensive care unit.
    Yi M, Wang P, Liu Y.
    Chin Med J (Engl); 2014 Apr 21; 127(6):1071-6. PubMed ID: 24622437
    [Abstract] [Full Text] [Related]

  • 9. Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa.
    Khalili Y, Yekani M, Goli HR, Memar MY.
    Acta Microbiol Immunol Hung; 2019 Dec 01; 66(4):529-540. PubMed ID: 31707785
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep 01; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 11. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G, Pollini S, Docquier JD, Almuzara M, Gutkind G, Rossolini GM, Radice M.
    Rev Panam Salud Publica; 2011 Dec 01; 30(6):545-8. PubMed ID: 22358400
    [Abstract] [Full Text] [Related]

  • 12. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul 01; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP, Xu YH, Wang ZX, Fang YP, Shen JL.
    Arch Microbiol; 2016 Aug 01; 198(6):565-71. PubMed ID: 27060003
    [Abstract] [Full Text] [Related]

  • 14. Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil.
    Campana EH, Xavier DE, Petrolini FV, Cordeiro-Moura JR, Araujo MR, Gales AC.
    Braz J Infect Dis; 2017 Aug 01; 21(1):57-62. PubMed ID: 27916604
    [Abstract] [Full Text] [Related]

  • 15. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.
    Int J Antimicrob Agents; 2010 May 01; 35(5):486-91. PubMed ID: 20185276
    [Abstract] [Full Text] [Related]

  • 16. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM.
    Arch Iran Med; 2015 Feb 01; 18(2):102-8. PubMed ID: 25644798
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN.
    J Antimicrob Chemother; 2014 Jul 01; 69(7):1804-14. PubMed ID: 24603963
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.
    Microb Drug Resist; 2013 Oct 01; 19(5):355-61. PubMed ID: 23600605
    [Abstract] [Full Text] [Related]

  • 19. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.
    Quale J, Bratu S, Gupta J, Landman D.
    Antimicrob Agents Chemother; 2006 May 01; 50(5):1633-41. PubMed ID: 16641429
    [Abstract] [Full Text] [Related]

  • 20. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC, Chia JH, Siu LK, Kuo AJ, Huang SH, Su LH, Wu TL.
    Int J Antimicrob Agents; 2012 Mar 01; 39(3):217-22. PubMed ID: 22079532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.